VaccinesArchives
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.
Vaccines 1 min.
Vaccines
1 min.
Published on 30/07/2026 |
Original article (Full-text)
| Qiu, Lingxian MD, et al. | Pediatric Infectious Disease Journal. Volume 45(8).
Current Oka strain varicella vaccines are generally safe but may cause latent neuronal infections leading to herpes zoster in some vaccinees. A novel v7D candidate vaccine has been developed to prevent varicella and reduce these risks. Methods: This randomized, double-blind, controlled, phase 2b clinical...
Breakthrough serogroup Y meningococcal disease in a vaccinated patient with myasthenia gravis receiving ravulizumab: a case report
Vaccines 1 min.
Vaccines
1 min.
Published on 23/07/2026 |
Original article (Full-text)
| Strugar, Silvija Šoprek et al. | BMC Infectious Diseases. Volume 26(1).
We report a case of fulminant invasive meningococcal disease caused by Neisseria meningitidis serogroup Y in a young, immunocompromised adult with myasthenia gravis receiving long-term immunosuppressive therapy including ravulizumab, despite prior meningococcal vaccination. Serogroup Y is increasingly...
